HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J M Nesland Selected Research

Cyclin A

3/2009A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice.
5/2005Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
5/2003Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas.
12/2001Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
11/2001Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
10/2001Coexpression of cyclin A and beta-catenin and survival in breast cancer patients.
7/2001Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.
9/2000Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J M Nesland Research Topics

Disease

35Neoplasms (Cancer)
09/2014 - 01/2000
23Carcinoma (Carcinomatosis)
02/2011 - 01/2000
19Breast Neoplasms (Breast Cancer)
04/2014 - 01/2000
10Neoplasm Metastasis (Metastasis)
04/2014 - 04/2000
4Ovarian Neoplasms (Ovarian Cancer)
01/2007 - 03/2000
4Colonic Neoplasms (Colon Cancer)
05/2005 - 03/2000
3Colorectal Neoplasms (Colorectal Cancer)
08/2012 - 11/2001
2Necrosis
09/2014 - 08/2001
2Carcinogenesis
09/2014 - 07/2001
2T-Cell Lymphoma (Lymphoma, T Cell)
09/2014 - 08/2001
2Malignant Mesothelioma
02/2011 - 09/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2008 - 10/2007
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2007 - 01/2007
2Ascites
11/2005 - 03/2000
2Adenocarcinoma
01/2004 - 11/2001
2Sarcoma (Soft Tissue Sarcoma)
11/2003 - 10/2001
2Melanoma (Melanoma, Malignant)
12/2001 - 09/2000
2Phototoxic Dermatitis (Phototoxicity)
08/2001 - 08/2001
2Disease Progression
11/2000 - 09/2000
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2014
1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2014
1Second Primary Neoplasms (Neoplasms, Second)
11/2013
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2013
1Mesothelioma
02/2011
1Leukemia
10/2010
1Lymphoma (Lymphomas)
01/2006
1Pathologic Neovascularization
01/2006
1Prostatic Neoplasms (Prostate Cancer)
01/2004
1Shock
06/2003

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
04/2014 - 01/2000
11Messenger RNA (mRNA)IBA
02/2011 - 01/2000
8Cyclin AIBA
03/2009 - 09/2000
6ErbB Receptors (EGF Receptor)IBA
03/2009 - 12/2000
6AntibodiesIBA
11/2006 - 04/2000
5Biological ProductsIBA
08/2012 - 09/2001
5Biomarkers (Surrogate Marker)IBA
08/2012 - 01/2004
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2009 - 01/2000
5Progesterone Receptors (Progesterone Receptor)IBA
07/2006 - 09/2001
5Cadherins (E-Cadherin)IBA
01/2005 - 01/2000
5ParaffinIBA
12/2001 - 04/2000
45-aminolevulinic acid hexyl esterFDA Link
09/2014 - 04/2007
4PorphyrinsIBA
08/2011 - 08/2001
41-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2011 - 08/2001
4Cyclin D1IBA
03/2009 - 03/2000
4Matrix Metalloproteinases (MMPs)IBA
01/2007 - 03/2001
4Estrogen ReceptorsIBA
09/2003 - 07/2001
3Keratins (Keratin)IBA
11/2006 - 05/2002
3CyclinsIBA
05/2005 - 09/2000
3Protein Isoforms (Isoforms)IBA
06/2003 - 01/2000
3beta CateninIBA
11/2002 - 01/2000
3Monoclonal AntibodiesIBA
12/2001 - 04/2000
3AntigensIBA
11/2001 - 04/2000
3AcidsIBA
09/2001 - 08/2001
3gamma Catenin (Plakoglobin)IBA
12/2000 - 01/2000
2DNA (Deoxyribonucleic Acid)IBA
09/2014 - 12/2001
2Peptide Hydrolases (Proteases)FDA Link
08/2012 - 03/2001
2Complementary DNA (cDNA)IBA
02/2008 - 07/2006
2protoporphyrin IXIBA
04/2007 - 08/2001
2Tissue Inhibitor of Metalloproteinase-2IBA
01/2007 - 11/2001
2Carrier Proteins (Binding Protein)IBA
11/2002 - 03/2000
2Transcription Factors (Transcription Factor)IBA
12/2001 - 03/2001
2Interleukin-8 (Interleukin 8)IBA
12/2001 - 01/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2001 - 03/2001
2Cyclin D3IBA
07/2001 - 09/2000
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2001 - 05/2001
2CarbohydratesIBA
09/2000 - 04/2000
2Sialyl Lewis X AntigenIBA
09/2000 - 04/2000
1Methoxsalen (Oxsoralen)FDA Link
09/2014
1MicroRNAs (MicroRNA)IBA
04/2014
1Cisplatin (Platino)FDA LinkGeneric
11/2013
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2012
1Small Interfering RNA (siRNA)IBA
08/2012
1Transforming Growth Factor alpha (TGF-alpha)IBA
03/2009
1Caspase 3 (Caspase-3)IBA
03/2009
1OligonucleotidesIBA
02/2008
1AsbestosIBA
01/2007
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2007
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2007
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2007
1Eph Family Receptors (Eph Receptors)IBA
01/2006
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2006
1Cyclin CIBA
05/2005
1CateninsIBA
01/2005
11,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA
01/2005
1VA 061 (VA061)IBA
01/2004
1AndrogensIBA
01/2004
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
01/2004
1Thymidylate SynthaseIBA
01/2004
1Thymidine PhosphorylaseIBA
01/2004
1Dental Implants (Dental Implant)IBA
11/2003
1Cathepsin DIBA
09/2003
1Plasminogen Activator Inhibitor 1IBA
01/2003

Therapy/Procedure

5Photochemotherapy (Photodynamic Therapy)
09/2014 - 08/2001
5Therapeutics
08/2012 - 07/2001
3Drug Therapy (Chemotherapy)
11/2013 - 03/2000
1Photopheresis
09/2014
1Radiotherapy
11/2013
1Transplantation
08/2011
1Laparotomy
11/2005
1Operative Surgical Procedures
11/2003